Bayer Ag Ord
(OP:
BAYZF
)
30.78
UNCHANGED
Streaming Delayed Price
Updated: 11:18 AM EDT, Aug 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Bayer Ag Ord
< Previous
1
2
3
Next >
Bayers Says Neuronal Stem Cell Therapy For Parkinson's Shows Encouraging Action In Early-Stage Study
June 28, 2023
Bayer AG (OTC: BAYRY) (OTC: BAYZF) and its subsidiary BlueRock Therapeutics LP announced
Via
Benzinga
US Court Favors Bayer In Lawsuit Against Merck On Talc Liabilities
April 04, 2023
Via
Benzinga
Bayer Seeks To Double US Revenues Over Next Decade, With Planned R&D Spending Of Around $1B
March 10, 2023
Bayer AG (OTC: BAYRY) intends to shell out around $1 billion on drug research and development in the U.S. in 2023 as it works to double its sales in the U.S. over the next ten years.
Via
Benzinga
Bayer Bolsters Its Position In Digital Medical Imaging With Acquisition Of UK-Based Firm
January 18, 2023
Via
Benzinga
FAA Technology Glitch Hits US Flights Operations, Coca-Cola & PepsiCo Under FTC Probe, Rivian Hit By Mass Executive Exodus: Today's Top Stories
January 11, 2023
Reuters
Via
Benzinga
Bayer's Kidney Disease Drug Disappoints On Cutting Cardiovascular Death
August 29, 2022
Via
Benzinga
FDA Approves Expanded Use For Bayer's Prostate Cancer Drug
August 08, 2022
Via
Benzinga
Activist Investor Builds Stake In Bayer, Pushes Breakup
January 11, 2023
Activist investor Bluebell Capital Partners has built a stake in Bayer AG (OTC: BAYRY) (OTC: BAYZF) and is pushing it to split up.
Via
Benzinga
Ionis Regains Rights To Thrombosis Candidate From Bayer
November 04, 2022
Via
Benzinga
Roundup Weedkiller Maker Bayer Won Five Consecutive Cases, Shifting Momentum In Bayer's Favor
October 05, 2022
Bayer AG (OTC: BAYRY) won five jury verdicts in a row in trials that contended its Roundup weed killer caused non-Hodgkin lymphoma. The company battles the remaining cases targeting its Roundup...
Via
Benzinga
After Investor Flak, German Healthcare Giant Bayer Starts Hunt For New CEO: Report
September 14, 2022
Via
Benzinga
Regeneron Gains As New Data Favors Higher Dose Of Flagship Eye Disease Drug
September 08, 2022
Via
Benzinga
Morning Brief: Top Financial Stories Dominating on Friday, June 10
June 10, 2022
Reuters Rebranded McDonald’s Restaurants To Reopen In Russia
Via
Benzinga
US Top Court To Decide On Bayer's Roundup Weedkiller Appeal
June 10, 2022
Via
Benzinga
Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara
May 20, 2022
Via
Benzinga
FDA Puts Blood Cancer Nods Under Scrutiny On Substantial Toxicity Profile Of PI3K Drugs
April 21, 2022
The FDA aims to put the PI3K inhibitor drug class under a more stringent regulatory scope as the inhibitor has demonstrated substantial toxicity.
Via
Benzinga
Eli Lilly To Suspend Sale Of 'Non-Essential' Medicines To Russia
March 15, 2022
Eli Lilly And Co (NYSE: LLY) said it would continue to supply drugs to Russia for urgent medical conditions such as cancer and diabetes but will suspend sales of "non-essential medicines."
Via
Benzinga
Exelixis Will Not Pursue Untreated Liver Cancer Indication For Cabometyx Combo Therapy
March 15, 2022
Exelixis Inc (NASDAQ: EXEL) announced results from the final analysis of the second primary endpoint of overall survival (OS) from the phase 3 COSMIC-312 trial of Cabometyx (cabozantinib) plus...
Via
Benzinga
Recursion, Bayer Expand Fibrosis Pact To Include Inferential Search Capabilities
December 06, 2021
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) expanded its existing strategic collaboration in fibrosis with Bayer AG (OTC: BAYRY). The expanded...
Via
Benzinga
Bayer's Nubeqa Shows Prolonged Survival In Late-Stage Prostate Cancer Trial
December 03, 2021
Bayer AG (OTC: BAYRY) said a combination therapy, including its Nubeqa drug, was shown to prolong the lives of men who have metastatic prostate cancer in a clinical...
Via
Benzinga
Microsoft, Bayer Collaborate To Develop Digital Agricultural Tools, Capabilities
November 17, 2021
Microsoft Corp (NASDAQ: MSFT) and Bayer AG (OTC: BAYRY) (OTC: BAYZF) collaborated on new internet-based products aimed at helping farmers and industries...
Via
Benzinga
Regeneron Touts Mid-Stage Win For Higher Dose Of Eylea In Age-related Macular Degeneration
August 24, 2021
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) revealed new Phase 2 proof-of-concept trial data on Eylea (aflibercept) injection in patients with wet age-related...
Via
Benzinga
Berkeley Lights, Bayer Ink Discovery Pact For Next-Gen Traits In Agricultural Sector, Berkeley Q2 Earnings Miss Estimates
August 11, 2021
Berkeley Lights Inc (NASDAQ: BLI) reports Q2 sales of $19.3 million, +82% Y/Y, but slightly missing the consensus of $19.64 million. The Company expanded the installed...
Via
Benzinga
Topics
Earnings
Exposures
Financial
Merck - Bayer's Heart Failure Treatment, Verquvo Scores European Nod
July 21, 2021
The European Commission (EC) has approved Merck & Co Inc's (NYSE: MRK) soluble guanylate cyclase (sGC) stimulator Verquvo (vericiguat). Verquvo...
Via
Benzinga
Bayer's Kerendia Scores Long-Awaited Kidney & Heart Disease Nod For Type 2 Diabetes
July 12, 2021
The FDA on Friday approved Bayer AG's (OTC: BAYRY) chronic kidney disease (CKD) drug Kerendia (finerenone), the first and only nonsteroidal mineralocorticoid...
Via
Benzinga
Exposures
Product Safety
Why Did Novocure Shares Plunge Today?
July 01, 2021
Novocure Ltd (NASDAQ: NVCR) has announced final results from its phase 2 pilot HEPANOVA trial evaluating Tumor Treating Fields (TTFields) together with Bayer...
Via
Benzinga
Exelixis Shares Drop On Mixed Results For Cabometyx Combo In Early Liver Cancer
June 28, 2021
Exelixis Inc (NASDAQ: EXEL) and Ipsen (OTC: IPSEY) have announced mixed interim results from the COSMIC-312 Phase 3 trial evaluating cabozantinib (...
Via
Benzinga
Bayer's Cell, Gene Therapies for Parkinson's Disease Enters Human Trials
June 08, 2021
Bayer AG’s (OTC: BAYRY) Parkinson’s disease stem cell therapy has officially landed in the clinic, while another treatment for the neurodegenerative...
Via
Benzinga
Bayer Buys Two Biotech Firms to Beef Up Radiopharmaceuticals
June 03, 2021
Bayer AG (OTC: BAYRY) will acquire two small biotech companies in a deal that adds an experimental prostate cancer medicine to the German drugmaker's pipeline...
Via
Benzinga
Bayer Mulls Ending US Retail Sales Of Weedkiller Glyphosate: Reuters
May 27, 2021
A U.S. judge rejected Bayer AG’s (OTC: BAYRY) plan to try and limit the cost of future class action claims that its Roundup weedkiller causes cancer, saying that...
Via
Benzinga
Exposures
Glyphosate
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.